✦ LIBER ✦

Comparison of thiomersal-free and thiomersal-containing formulations of a recombinant hepatitis B vaccine (Hepavax-Gene®) in healthy adults

✍ Scribed by I. Rebedea; I.G. Diaconescu; D. Bach; O. Bartelsen; N. Arndtz

Book ID: 116958914
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 231 KB
Volume: 24
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2006.04.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I clinical trial in healthy adults

Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens

✍ Arístides Aguilar Betancourt; C.A. González Delgado; Z. Cinza Estévez; J. Cabrer 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 227 KB

High Seroprotection Rate Induced by Intr

High Seroprotection Rate Induced by Intradermal Administration of a Recombinant Hepatitis B Vaccine in Young Healthy Adults: Comparison with Standard Intramuscular Vaccination

✍ Mohammad J. Ghabouli; Amir Hossein Sabouri; Naser Shoeibi; Sepideh Naghibzadeh B 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 83 KB

Immunogenicity and safety of a novel yea

Immunogenicity and safety of a novel yeast Hansenula polymorpha-derived recombinant Hepatitis B candidate vaccine in healthy adolescents and adults aged 10–45 years

✍ Miguel W. Tregnaghi; Ricardo Voelker; Eduardo Santos-Lima; Betzana Zambrano 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 428 KB

Immunogenicity of 20 μg of recombinant D

Immunogenicity of 20 μg of recombinant DNA hepatitis B vaccine in healthy neonates: A comparison of three different vaccination schemes

✍ R. Del Canho; P. M. Grosheide; M. Voogd; W. M. Huisman; R. A. Heijtink; Dr. S. W 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 558 KB

## Abstract The immunogenicity of a full dose (20 μg) of recombinant DNA yeast‐derived hepatitis B vaccine (Engerix‐B) was assessed in healthy neonates in order to compare three candidate vaccination schemes. After randomization 162 newborns of hepatitis B surface antigen (HBsAg) negative mothers e

Comparison of the safety and immunogenic

Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults

✍ Scott A. Halperin; Simon Dobson; Shelly McNeil; Joanne M. Langley; Bruce Smith; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Comparison of safety and immunogenicity

Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18–55 years of age

✍ Scott A. Halperin; Brian Ward; Curtis Cooper; Gerald Predy; Francisco Diaz-Mitom 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 344 KB